Liz Moody

And then you essentially have to buy a lot of Hermes, like other products from Hermes, and develop a relationship with a store associate before you're even offered the opportunity to buy a Birkin.

That process, that scarcity, which...

It's so silly and insane that we're down to participate in this.

But that process of creating scarcity is what creates the perceived value.

If everybody could just go get one by cost or opportunity or both, the perceived value would go down.

Historically, our societal standard of beauty has been available to a pretty small percentage of people.

And a lot of that had to do with essentially how you were born looking.

But now because of GLP-1s, being thin is available to anybody who can afford it.

One in eight people in America are on GLP-1s.

And I want to be clear, I am not anti-GLP-1s.

I'm actually pretty pro-GLP-1s.

I think that the research coming out about cancer is really compelling.

The research coming out about inflammation is really compelling.

We're actually working on an episode about whether this is a drug that more of us should be taking for the longevity benefits.

And they have made what was once a status symbol of this very thin body available to anybody who can afford to take these injections, which decreases the status of that type of body.

Because again, status comes from scarcity.

We can get fillers to make our lips fuller, to make our face more symmetrical.

We can get Botox to smooth fine lines.

We can get nose jobs and upper blepharoplasties.

And we know about all of these procedures in a way that we absolutely did not used to.